C12N 2710/14044
Chimeric viral vector comprising heterologous viral elements for production of another viral
Official title: Chimeric viral vector comprising heterologous viral elements for production of another viral vector
C12N2710/14044 (Chimeric viral vector comprising heterologous viral elements for production of another viral) appears on 26 US grants and 60 published applications in this corpus.
Search patents in C12N- Granted patents
- 26
- Published applications
- 60
- Assignees
- 27
- Inventors
- 96
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 2 |
| 2014 | 1 | 4 |
| 2015 | 1 | 3 |
| 2016 | 0 | 1 |
| 2017 | 2 | 2 |
| 2018 | 5 | 7 |
| 2019 | 2 | 3 |
| 2020 | 3 | 4 |
| 2021 | 1 | 4 |
| 2022 | 3 | 6 |
| 2023 | 2 | 6 |
| 2024 | 1 | 10 |
| 2025 | 2 | 4 |
| 2026 | 2 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Treatment of ocular neovascularization using anti-vegf proteins26 May 2026US 12,636,348 B2Avalanche Australia Pty Ltd.
- AAV transfer cassette28 Apr 2026US 12,611,436 B2Sarepta Therapeutics, Inc.
- AAV vectors produced by insect cells comprising Rep52 and Rep78 coding sequences with differential codon biases2 Dec 2025US 12,486,496 B2uniQure IP B.V.
- Preparation method and system for recombinant adeno-associated virus, and recombinant bacmid1 Jul 2025US 12,344,856 B2Genevoyager (Wuhan) Co., Ltd.
- Adeno-associated viral vectors for treatment of Niemann-Pick Disease type-C20 Feb 2024US 11,905,523 B2Ginkgo Bioworks, Inc.
- Controlled expression of viral proteins26 Mar 2026US 2026/0085328 A1Voyager Therapeutics, Inc.
- Aav vectors produced by insect cells comprising rep52 and rep78 coding sequences with differential codon biases5 Feb 2026US 2026/0035674 A1uniQure IP B.V.
- Baculovirus expression system13 Nov 2025US 2025/0346920 A1Voyager Therapeutics, Inc.
- Insect cell-produced high potency AAV vectors with CNS-tropism25 Sep 2025US 2025/0297278 A1uniQure biopharma B.V.
- Large scale adeno-associated virus production systems13 Mar 2025US 2025/0084383 A1Biomarin Pharmaceutical Inc.
Most cited
By later US patents
- Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAV45US 8,512,981 B2Amsterdam Molecular Therapeutics B.V. · 2013
- Baculoviral vectors comprising repeated coding sequences with differential codon biases37US 8,697,417 B2uniQure IP B.V. · 2014
- Baculoviral vectors comprising repeated coding sequences with differential codon biases34US 9,580,691 B2uniQure IP B.V. · 2017
- Treatment of ocular neovascularization using anti-VEGF proteins20US 10,004,788 B2Avalanche Australia Pty Ltd. · 2018
- Treatment of ocular neovascularization using anti-VEGF proteins20US 9,943,573 B2Avalanche Australia Pty Ltd. · 2018